AptarGroup, Inc. (ATR) Stock

AptarGroup, Inc. (ATR) is a Materials stock trading at $134.83 (as of 2026-08-21), with a market capitalization of $8.57B and a trailing P/E of 23.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

AptarGroup, Inc. develops dispensing, sealing, and material science components for markets including beauty, personal care, home care, prescription drugs, consumer healthcare, injectables, and food and beverage. It operates through Pharma, Beauty + Home, and Food + Beverage segments, serving customers via its own sales force and independent representatives and distributors.

Understand AptarGroup, Inc.: how it makes money

AptarGroup makes dispensing, sealing, and material science solutions sold into beauty and personal care, home care, prescription drug, consumer health care, injectable drug delivery, and food and beverage markets.

Profit is driven by turning dispensing, sealing, and material science know-how into product components and related solutions used across Pharma, Beauty + Home, and Food + Beverage end markets.

Business quality (Mixed): Segment revenue detail is not provided here, so the clearest supported read-through is the companys three official end-market segments and the stated operating margin and currency translation benefit.

Valuation: At 20× earnings, ATR trades 15% below the Rubber & Plastic Products average (24×). Note: one-time items can distort reported P/E.

Bull case

  • Diverse application footprint: AptarGroup serves multiple end markets through its three reportable segments, Pharma, Beauty + Home, and Food + Beverage.
  • Operating profitability exists at the latest period shown: Operating margin for the quarter ended 2026-03-31 is shown as 10.9%.

Bear case

  • Foreign exchange can move reported results: A Currency Translation Benefit of 3.0% is cited for the period, implying FX can materially affect reported performance.
  • Market concentration by application: Key offerings described include pumps for nasal allergy treatments, metered dose inhaler valves, and injectable primary packaging elastomer, which ties results to those pharmaceutical and consumer health care demand areas.
Valuation — source: SEC EDGAR (first-party)
Price$134.83
Market Cap$8.57B
P/E Ratio23.6
EV / EBITDA10.7
Price / Book3.24
Price / Sales2.18
FCF Yield3.6%
DCF Value (model)$103.26
DCF Upside vs Price-23.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$3.78B
Net Margin10.4%
Revenue Growth (YoY)6.3%
EPS Growth (YoY)-18.3%
FCF Growth (YoY)-26.6%
Financial Health — source: SEC EDGAR
Altman Z-Score3.93 (safe)
Valuation vs Sector & Industry
Stock P/E23.6
Sector P/E (Materials)25.9
Industry P/E (Rubber & Plastic Products)24.5
vs Sector-8.7%
vs Industry-3.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($843.78M)
Institutional Holders Tracked10
Congressional Trades (recent)1
Company
SectorMaterials
IndustryRubber & Plastic Products
CEOStephan Tanda
Employees13,000
CountryUS
IPO Date1993-04-23

Related Companies (Rubber & Plastic Products; 8 comparable companies)

  • Newell Brands Inc. (NWL)
  • Armstrong World Industries, Inc. (AWI)
  • Entegris, Inc. (ENTG)
  • Myers Industries, Inc. (MYE)
  • Latham Group, Inc. (SWIM)
  • Karat Packaging Inc. (KRT)
  • Advanced Drainage Systems, Inc. (WMS)
  • Carlisle Companies Incorporated (CSL)
ATR earnings history · ATR institutional & insider holders · ATR KPIs & operating metrics · ATR financials · ATR investor presentations & press releases · ATR SEC filings · ATR peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.